v3.24.3
CONDENSED CONSOLIDATED STATMENTS OF STOCKHOLDERS' EQUITY - USD ($)
shares in Thousands, $ in Thousands
Total
Common Stock
Additional Paid-In Capital
Accumulated Other Comprehensive Loss
Accumulated Deficit
Beginning balance (in shares) at Jan. 31, 2023   214,293      
Beginning balance at Jan. 31, 2023 $ 356,574 $ 2 $ 1,595,001 $ (873) $ (1,237,556)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Issuance of common stock upon the exercise of options (in shares)   1,649      
Issuance of common stock upon the exercise of options 3,856   3,856    
Vesting of early exercised stock options 108   108    
Issuance of common stock upon the vesting and settlement of restricted stock units (in shares)   5,584      
Issuance of common stock upon the vesting and settlement of restricted stock units (7)   (7)    
Issuance of common stock under employee share purchase plan (in shares)   878      
Issuance of common stock under employee share purchase plan 15,069   15,069    
Stock-based compensation expense 153,606   153,606    
Net unrealized gains (losses) on marketable securities (1,251)     (1,251)  
Foreign currency translation adjustments (1,154)     (1,154)  
Net loss (194,632)       (194,632)
Ending balance (in shares) at Oct. 31, 2023   222,404      
Ending balance at Oct. 31, 2023 332,169 $ 2 1,767,633 (3,278) (1,432,188)
Beginning balance (in shares) at Jul. 31, 2023   219,606      
Beginning balance at Jul. 31, 2023 334,253 $ 2 1,706,006 (1,317) (1,370,438)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Issuance of common stock upon the exercise of options (in shares)   278      
Issuance of common stock upon the exercise of options 783   783    
Vesting of early exercised stock options 2   2    
Issuance of common stock upon the vesting and settlement of restricted stock units (in shares)   2,100      
Issuance of common stock upon the vesting and settlement of restricted stock units 0        
Issuance of common stock under employee share purchase plan (in shares)   420      
Issuance of common stock under employee share purchase plan 6,511   6,511    
Stock-based compensation expense 54,331   54,331    
Net unrealized gains (losses) on marketable securities (236)     (236)  
Foreign currency translation adjustments (1,725)     (1,725)  
Net loss (61,750)       (61,750)
Ending balance (in shares) at Oct. 31, 2023   222,404      
Ending balance at Oct. 31, 2023 332,169 $ 2 1,767,633 (3,278) (1,432,188)
Beginning balance (in shares) at Jan. 31, 2024   224,728      
Beginning balance at Jan. 31, 2024 $ 326,396 $ 2 1,821,216 (236) (1,494,586)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Issuance of common stock upon the exercise of options (in shares) 1,412 1,412      
Issuance of common stock upon the exercise of options $ 3,884   3,884    
Repurchases and retirement of common stock (in shares)   (5,940)      
Repurchases and retirement of common stock (74,690)       (74,690)
Issuance of common stock upon the vesting and settlement of restricted stock units (in shares)   7,252      
Issuance of common stock upon the vesting and settlement of restricted stock units (5)   (5)    
Issuance of common stock under employee share purchase plan (in shares)   1,119      
Issuance of common stock under employee share purchase plan 13,665   13,665    
Stock-based compensation expense 164,004   164,004    
Net unrealized gains (losses) on marketable securities 71     71  
Foreign currency translation adjustments (818)     (818)  
Net loss (193,237)       (193,237)
Ending balance (in shares) at Oct. 31, 2024   228,571      
Ending balance at Oct. 31, 2024 239,270 $ 2 2,002,764 (983) (1,762,513)
Beginning balance (in shares) at Jul. 31, 2024   229,489      
Beginning balance at Jul. 31, 2024 291,917 $ 2 1,942,911 (778) (1,650,218)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Issuance of common stock upon the exercise of options (in shares)   739      
Issuance of common stock upon the exercise of options 1,755   1,755    
Repurchases and retirement of common stock (in shares)   (4,494)      
Repurchases and retirement of common stock (54,969)       (54,969)
Issuance of common stock upon the vesting and settlement of restricted stock units (in shares)   2,372      
Issuance of common stock upon the vesting and settlement of restricted stock units (1)   (1)    
Issuance of common stock under employee share purchase plan (in shares)   465      
Issuance of common stock under employee share purchase plan 4,799   4,799    
Stock-based compensation expense 53,300   53,300    
Net unrealized gains (losses) on marketable securities 33     33  
Foreign currency translation adjustments (238)     (238)  
Net loss (57,326)       (57,326)
Ending balance (in shares) at Oct. 31, 2024   228,571      
Ending balance at Oct. 31, 2024 $ 239,270 $ 2 $ 2,002,764 $ (983) $ (1,762,513)